Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
Fernández
Alejandra
A
Velasco
Antonio
A
Prieto
Vanesa
V
Canueto
Javier
J
Alvarez
Alberto
A
Rodríguez
Antonio
A
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D017511:Pyoderma Gangrenosum / Q000188:drug therapy* / Q000209:etiology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab